Skip to main content
Top
Published in: Clinical Journal of Gastroenterology 5/2018

01-10-2018 | Case Report

Early gastric cancer with lymphoid stroma presenting as a subepithelial lesion diagnosed by endoscopic submucosal dissection

Authors: Minoru Kato, Yoshito Hayashi, Kenji Fukumoto, Kengo Nagai, Yoshiki Tsujii, Shinichiro Shinzaki, Hideki Iijima, Tetsuo Takehara

Published in: Clinical Journal of Gastroenterology | Issue 5/2018

Login to get access

Abstract

A 53-year-old man underwent an esophagogastroduodenoscopy that showed a 20-mm subepithelial lesion in the middle gastric body. Endoscopic ultrasound revealed a hypoechoic mass located in the submucosa. Biopsy specimens revealed a benign gastric mucosa with severe lymphocytic infiltration in the submucosa. Malignant lymphoma or gastric cancer with lymphoid stroma was suspected. We performed endoscopic submucosal dissection for definitive diagnosis. Histological examination showed undifferentiated adenocarcinoma, which showed positive Epstein–Barr virus-encoded RNA in situ hybridization results, invading the submucosa mixed with dense lymphocytic infiltration. Thus, Epstein–Barr virus-positive gastric cancer with lymphoid stroma was diagnosed. Gastric cancer with lymphoid stroma is a rare subtype of gastric cancer, which is associated with Epstein–Barr virus infection; it sometimes appears as a subepithelial lesion, which makes it difficult to diagnose using standard biopsy. Endoscopic submucosal dissection was useful in obtaining a sufficient tissue for full histological assessment, including immunostaining.
Literature
1.
go back to reference Watanabe H, Enjoji M, Imai T. Gastric carcinoma with lymphoid stroma. Its morphologic characteristics and prognostic correlations. Cancer. 1976;38:232–43.CrossRef Watanabe H, Enjoji M, Imai T. Gastric carcinoma with lymphoid stroma. Its morphologic characteristics and prognostic correlations. Cancer. 1976;38:232–43.CrossRef
2.
go back to reference Burke AP, Yen TS, Shekitka KM, et al. Lymphoepithelial carcinoma of the stomach with Epstein–Barr virus demonstrated by polymerase chain reaction. Mod Pathol. 1990;3:377–80.PubMed Burke AP, Yen TS, Shekitka KM, et al. Lymphoepithelial carcinoma of the stomach with Epstein–Barr virus demonstrated by polymerase chain reaction. Mod Pathol. 1990;3:377–80.PubMed
3.
4.
go back to reference Shin DH, Kim GH, Lee BE, et al. Clinicopathologic features of early gastric carcinoma with lymphoid stroma and feasibility of endoscopic submucosal dissection. Surg Endosc. 2017;31:4156–64.CrossRef Shin DH, Kim GH, Lee BE, et al. Clinicopathologic features of early gastric carcinoma with lymphoid stroma and feasibility of endoscopic submucosal dissection. Surg Endosc. 2017;31:4156–64.CrossRef
5.
go back to reference Zhang XC, Li QL, Yu YF, et al. Diagnostic efficacy of endoscopic ultrasound-guided needle sampling for upper gastrointestinal subepithelial lesions: a meta-analysis. Surg Endosc. 2016;30:2431–41.CrossRef Zhang XC, Li QL, Yu YF, et al. Diagnostic efficacy of endoscopic ultrasound-guided needle sampling for upper gastrointestinal subepithelial lesions: a meta-analysis. Surg Endosc. 2016;30:2431–41.CrossRef
6.
go back to reference Kang GH, Lee S, Kim WH, et al. Epstein–Barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitute CpG island. Am J Pathol. 2002;160:787–94.CrossRef Kang GH, Lee S, Kim WH, et al. Epstein–Barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitute CpG island. Am J Pathol. 2002;160:787–94.CrossRef
7.
go back to reference Kaizaki Y, Sakurai S, Chong JM, et al. Atrophic gastritis, Epstein–Barr virus infection, and Epstein–Barr virus-associated gastric carcinoma. Gastric Cancer. 1999;2:101–8.CrossRef Kaizaki Y, Sakurai S, Chong JM, et al. Atrophic gastritis, Epstein–Barr virus infection, and Epstein–Barr virus-associated gastric carcinoma. Gastric Cancer. 1999;2:101–8.CrossRef
8.
go back to reference Arikawa J, Tokunaga M, Satoh E, et al. Morphological characteristics of Epstein–Barr virus-related early gastric carcinoma: a case–control study. Pathol Int. 1997;47:360–7.CrossRef Arikawa J, Tokunaga M, Satoh E, et al. Morphological characteristics of Epstein–Barr virus-related early gastric carcinoma: a case–control study. Pathol Int. 1997;47:360–7.CrossRef
9.
go back to reference Association Japanese Gastric Cancer. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011;14:113–23.CrossRef Association Japanese Gastric Cancer. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011;14:113–23.CrossRef
10.
go back to reference Lim H, Lee SI, Lee JH, et al. Clinical application of early gastric carcinoma with lymphoid stroma based on lymph node metastasis status. Gastric Cancer. 2017;20:793–801.CrossRef Lim H, Lee SI, Lee JH, et al. Clinical application of early gastric carcinoma with lymphoid stroma based on lymph node metastasis status. Gastric Cancer. 2017;20:793–801.CrossRef
11.
go back to reference Tokunaga M, Land CE. Epstein–Barr virus involvement in gastric cancer: biomarker for lymph node metastasis. Cancer Epidemiol Biomark Prev. 1998;7:449–50. Tokunaga M, Land CE. Epstein–Barr virus involvement in gastric cancer: biomarker for lymph node metastasis. Cancer Epidemiol Biomark Prev. 1998;7:449–50.
12.
go back to reference Park JH, Kim EK, Kim YH, et al. Epstein–Barr virus positivity, not mismatch repair deficiency, is a favorable risk factor for lymph node metastasis in submucosa-invasive early gastric cancer. Gastric Cancer. 2016;19:1041–51.CrossRef Park JH, Kim EK, Kim YH, et al. Epstein–Barr virus positivity, not mismatch repair deficiency, is a favorable risk factor for lymph node metastasis in submucosa-invasive early gastric cancer. Gastric Cancer. 2016;19:1041–51.CrossRef
13.
go back to reference Gromski MA, Miller CA, Lee SH, et al. Gastric lymphoepithelioma-like carcinoma mimicking a subepithelial lesion treated by endoscopic submucosal dissection. Gastrointest Endosc. 2012;76:419–21.CrossRef Gromski MA, Miller CA, Lee SH, et al. Gastric lymphoepithelioma-like carcinoma mimicking a subepithelial lesion treated by endoscopic submucosal dissection. Gastrointest Endosc. 2012;76:419–21.CrossRef
14.
go back to reference Lee HL, Kim DC, Lee SP, et al. Treatment of Epstein–Barr virus-associated gastric carcinoma with endoscopic submucosal dissection. Gastrointest Endosc. 2012;76:913–5.CrossRef Lee HL, Kim DC, Lee SP, et al. Treatment of Epstein–Barr virus-associated gastric carcinoma with endoscopic submucosal dissection. Gastrointest Endosc. 2012;76:913–5.CrossRef
15.
go back to reference Lee JY, Kim KM, Min BH, et al. Epstein–Barr virus-associated lymphoepithelioma-like early gastric carcinomas and endoscopic submucosal dissection. World J Gastroenterol. 2014;20:1365–70.CrossRef Lee JY, Kim KM, Min BH, et al. Epstein–Barr virus-associated lymphoepithelioma-like early gastric carcinomas and endoscopic submucosal dissection. World J Gastroenterol. 2014;20:1365–70.CrossRef
16.
go back to reference Kaizaki Y, Hosokawa O, Sakurai S, et al. Epstein–Barr virus-associated gastric carcinoma in the remnant stomach: de novo and metachronous gastric remnant carcinoma. J Gastroenterol. 2005;40:570–7.CrossRef Kaizaki Y, Hosokawa O, Sakurai S, et al. Epstein–Barr virus-associated gastric carcinoma in the remnant stomach: de novo and metachronous gastric remnant carcinoma. J Gastroenterol. 2005;40:570–7.CrossRef
17.
go back to reference Matsunou H, Konishi F, Hori H, et al. Characteristics of Epstein–Barr virus-associated gastric carcinoma with lymphoid stroma in Japan. Cancer. 1996;77:1998–2004.CrossRef Matsunou H, Konishi F, Hori H, et al. Characteristics of Epstein–Barr virus-associated gastric carcinoma with lymphoid stroma in Japan. Cancer. 1996;77:1998–2004.CrossRef
Metadata
Title
Early gastric cancer with lymphoid stroma presenting as a subepithelial lesion diagnosed by endoscopic submucosal dissection
Authors
Minoru Kato
Yoshito Hayashi
Kenji Fukumoto
Kengo Nagai
Yoshiki Tsujii
Shinichiro Shinzaki
Hideki Iijima
Tetsuo Takehara
Publication date
01-10-2018
Publisher
Springer Japan
Published in
Clinical Journal of Gastroenterology / Issue 5/2018
Print ISSN: 1865-7257
Electronic ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-018-0855-3

Other articles of this Issue 5/2018

Clinical Journal of Gastroenterology 5/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.